From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

DHS Standardized Test and Evaluation of Biological Threat Agent Detectors

by Global Biodefense Staff
May 15, 2013

Pandemic PreparednessThe U.S Department of Homeland Security (DHS) has selected Health Research Inc. with the Wadsworth Center, New York State Department of Health to develop standard test methods to support field evaluation of technologies used for biological agent detection.

The proposed work will address current gaps in standards by defining field testing needs, methods and performance requirements. The resulting deliverables will include products that will serve as the basis of a national standard for biothreat equipment.

The work requires interaction with the entire biological event response chain including: members of the Laboratory Response Network, National Guard WMD Civil Support Teams, Hazardous Material response units, Federal Bureau of Investigation (FBI) weapons of mass destruction coordinators, Environmental Protection Agency (EPA) and representatives from regional, state and local response units. 

In further describing why Wadsworth Center and Health Research Inc. were selected, DHS states that because the existing Stakeholder Panel for Agent Detection Assays (SPADA) is the only national standard for biothreat detection and device testing, and will be the basis for the field testing for this effort, it is important the performer have experience with the development of biothreat standards as established by SPADA.

The effort is overseen by the DHS, Science and Technology Directorate, Standards Office, Acquisition Support & Operations Analysis, Biological Countermeasures Standards program. Further details are available at FBO.gov. 

Health Research, Inc. is a not-for-profit corporation affiliated with the New York State Department of Health (DOH) and the Roswell Park Cancer Institute (RPCI) a leading cancer research center located in Buffalo, New York.

From Our Partners
Tags: DHSMobile Response

Related Posts

Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools
Biodetection

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC